Index by author

December 1, 2022; Volume 63,Issue 12

  1. Chung, Benjamin I.

    1. <sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
      68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
      Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1822-1828; DOI: https://doi.org/10.2967/jnumed.122.263897

  2. Chung, Benjamin Inbeh

    1. Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
      Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
      Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1829-1835; DOI: https://doi.org/10.2967/jnumed.122.263971

  3. Clausen, Malene M.

    1. First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic
      First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
      Mathias Loft, Camilla Christensen, Malene M. Clausen, Esben A. Carlsen, Carsten P. Hansen, Niels Kroman, Seppo W. Langer, Claus Høgdall, Jacob Madsen, Nic Gillings, Carsten H. Nielsen, Thomas L. Klausen, Søren Holm, Annika Loft, Anne K. Berthelsen and Andreas Kjaer
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1871-1879; DOI: https://doi.org/10.2967/jnumed.122.264068

  4. Clerc, Jérôme

    1. <sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
      Open Access
      18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
      Kibrom B. Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1925-1932; DOI: https://doi.org/10.2967/jnumed.121.263501

  5. Coolen, Bram F.

    1. <sup>89</sup>Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
      89Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
      Kang H. Zheng, Jeffrey Kroon, Jasper Schoormans, Oliver Gurney-Champion, Sybren L. Meijer, Suzanne S. Gisbertz, Maarten C.C.M. Hulshof, Danielle J. Vugts, Guus A.M.S. van Dongen, Bram F. Coolen, Hein J. Verberne, Aart J. Nederveen, Erik S.G. Stroes and Hanneke W.M. van Laarhoven
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1880-1886; DOI: https://doi.org/10.2967/jnumed.121.263330

  6. Cordes, Michael

    1. Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging
      Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, Michael Cordes, Georg Schett, Andreas Ramming and Theresa Götz
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1786-1792; DOI: https://doi.org/10.2967/jnumed.122.264205

  7. Cottereau, Anne-Ségolène

    1. <sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
      Open Access
      18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
      Kibrom B. Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1925-1932; DOI: https://doi.org/10.2967/jnumed.121.263501

  8. Cousin, François

    1. Using <sup>68</sup>Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice
      Using 68Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice
      Chloé S. Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R. Sautois and Nadia Withofs
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1815-1821; DOI: https://doi.org/10.2967/jnumed.121.263611

  9. Dannenberg, Varius

    1. Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy
      Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy
      Christian Nitsche, Katharina Mascherbauer, Raffaella Calabretta, Matthias Koschutnik, Carolina Dona, Varius Dannenberg, Felix Hofer, Kseniya Halavina, Andreas A. Kammerlander, Tatjana Traub-Weidinger, Georg Goliasch, Christian Hengstenberg, Marcus Hacker and Julia Mascherbauer
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1906-1911; DOI: https://doi.org/10.2967/jnumed.122.264041

  10. Davidzon, Guido A.

    1. Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
      Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
      Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1829-1835; DOI: https://doi.org/10.2967/jnumed.122.263971
    2. <sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
      68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
      Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1822-1828; DOI: https://doi.org/10.2967/jnumed.122.263897
« Previous (Pages : 1 2 3 4 5 6 7 8 9 10 ... 31) Next »
Back to top

In this issue